La CND organisera des "réunions thématiques" pour aborder les questions encore en suspens concernant les implications des réglementations relatives au cannabis proposées par l'OMS et augmenter les chances que celles-ci soient adoptées lors de la reprise de sa 63e session. Pour en savoir plus, en anglais, veuillez lire les informations ci-dessous.
ByMarijuana Buisiness Daily
A document prepared by the chair of the United Nations Commission on Narcotic Drugs (CND) has laid out a course to keep on track for December’s key vote on the World Health Organization’s cannabis scheduling recommendations.
This is positive news for industry stakeholders concerned about a possible delay stemming from the coronavirus crisis. While the likely outcome of the vote is not yet known, it could have far-reaching implications for the global cannabis industry.
One recommendation, for instance, would recognize the medical value and a lesser potential for harm of cannabis at a U.N. level – making it easier for member countries to adopt medical cannabis programs.
Another recommendation would ease restrictions on CBD products.
Marijuana Business Daily obtained the letter, which was being circulated among CND-member nations earlier in May. It is an updated version of a document shared at the end of April, taking into consideration comments and requests made by member countries.